vs

Side-by-side financial comparison of American Express (AXP) and KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). Click either name above to swap in a different company.

KESTRA MEDICAL TECHNOLOGIES, LTD. is the larger business by last-quarter revenue ($22.6M vs $18.9M, roughly 1.2× American Express). American Express runs the higher net margin — 15.7% vs -145.3%, a 161.0% gap on every dollar of revenue.

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

AXP vs KMTS — Head-to-Head

Bigger by revenue
KMTS
KMTS
1.2× larger
KMTS
$22.6M
$18.9M
AXP
Higher net margin
AXP
AXP
161.0% more per $
AXP
15.7%
-145.3%
KMTS

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
AXP
AXP
KMTS
KMTS
Revenue
$18.9M
$22.6M
Net Profit
$3.0M
$-32.8M
Gross Margin
50.6%
Operating Margin
-140.7%
Net Margin
15.7%
-145.3%
Revenue YoY
11.4%
Net Profit YoY
15.0%
EPS (diluted)
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXP
AXP
KMTS
KMTS
Q1 26
$18.9M
Q4 25
$10.9B
$22.6M
Q3 25
$10.4B
$19.4M
Q2 25
$10.3B
Q1 25
$9.6B
Q4 24
$10.0B
Q3 24
$9.7B
Q2 24
$9.8B
Net Profit
AXP
AXP
KMTS
KMTS
Q1 26
$3.0M
Q4 25
$2.5B
$-32.8M
Q3 25
$2.9B
$-25.8M
Q2 25
$2.9B
Q1 25
$2.6B
Q4 24
$2.2B
Q3 24
$2.5B
Q2 24
$3.0B
Gross Margin
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
50.6%
Q3 25
45.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
28.2%
-140.7%
Q3 25
36.7%
-149.1%
Q2 25
34.4%
Q1 25
34.6%
Q4 24
27.7%
Q3 24
33.0%
Q2 24
38.6%
Net Margin
AXP
AXP
KMTS
KMTS
Q1 26
15.7%
Q4 25
22.5%
-145.3%
Q3 25
27.9%
-133.3%
Q2 25
28.0%
Q1 25
26.8%
Q4 24
21.8%
Q3 24
25.8%
Q2 24
30.7%
EPS (diluted)
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
$3.52
$-0.64
Q3 25
$4.14
$-0.50
Q2 25
$4.08
Q1 25
$3.64
Q4 24
$3.04
Q3 24
$3.49
Q2 24
$4.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXP
AXP
KMTS
KMTS
Cash + ST InvestmentsLiquidity on hand
$175.4M
Total DebtLower is stronger
$60.4M
Stockholders' EquityBook value
$34.0M
$164.1M
Total Assets
$308.9M
$246.7M
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
$742.0M
$175.4M
Q3 25
$1.3B
$201.2M
Q2 25
$197.0M
Q1 25
$261.0M
Q4 24
$221.0M
Q3 24
$120.0M
Q2 24
$188.0M
Total Debt
AXP
AXP
KMTS
KMTS
Q1 26
$60.4M
Q4 25
$56.4B
Q3 25
$57.8B
Q2 25
$58.2B
Q1 25
$51.2B
Q4 24
$49.7B
Q3 24
$53.5B
Q2 24
$51.5B
Stockholders' Equity
AXP
AXP
KMTS
KMTS
Q1 26
$34.0M
Q4 25
$33.5B
$164.1M
Q3 25
$32.4B
$184.2M
Q2 25
$32.3B
Q1 25
$31.2B
Q4 24
$30.3B
Q3 24
$29.7B
Q2 24
$29.5B
Total Assets
AXP
AXP
KMTS
KMTS
Q1 26
$308.9M
Q4 25
$300.1B
$246.7M
Q3 25
$297.6B
$266.3M
Q2 25
$295.6B
Q1 25
$282.2B
Q4 24
$271.5B
Q3 24
$271.0B
Q2 24
$272.2B
Debt / Equity
AXP
AXP
KMTS
KMTS
Q1 26
1.78×
Q4 25
1.68×
Q3 25
1.78×
Q2 25
1.80×
Q1 25
1.64×
Q4 24
1.64×
Q3 24
1.80×
Q2 24
1.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXP
AXP
KMTS
KMTS
Operating Cash FlowLast quarter
$-18.3M
Free Cash FlowOCF − Capex
$-25.6M
FCF MarginFCF / Revenue
-113.5%
Capex IntensityCapex / Revenue
32.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
$3.1B
$-18.3M
Q3 25
$6.2B
$-26.3M
Q2 25
$4.4B
Q1 25
$4.8B
Q4 24
$5.8B
Q3 24
$-1.8B
Q2 24
$4.5B
Free Cash Flow
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
$2.3B
$-25.6M
Q3 25
$5.6B
$-34.4M
Q2 25
$3.7B
Q1 25
$4.3B
Q4 24
$5.3B
Q3 24
$-2.3B
Q2 24
$4.0B
FCF Margin
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
21.4%
-113.5%
Q3 25
53.6%
-177.8%
Q2 25
36.3%
Q1 25
45.0%
Q4 24
53.1%
Q3 24
-23.3%
Q2 24
40.4%
Capex Intensity
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
6.6%
32.2%
Q3 25
6.3%
42.2%
Q2 25
6.0%
Q1 25
4.5%
Q4 24
5.0%
Q3 24
4.7%
Q2 24
5.8%
Cash Conversion
AXP
AXP
KMTS
KMTS
Q1 26
Q4 25
1.25×
Q3 25
2.15×
Q2 25
1.51×
Q1 25
1.84×
Q4 24
2.66×
Q3 24
-0.72×
Q2 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXP
AXP

Discount revenue$9.5M50%
Other$8.9M47%
Deposits with banks and other$512.0K3%

KMTS
KMTS

Segment breakdown not available.

Related Comparisons